Al-Aly Z, Rosen CJ (2024) Long covid and impaired cognition—more evidence and more work to do. N Engl J Med 390:858–860. https://doi.org/10.1056/NEJMe2400189
Article PubMed PubMed Central Google Scholar
Al-Aly Z, Bowe B, Xie Y (2022) Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 28:7 [Internet] [cited 2024 May 13]. https://www.nature.com/articles/s41591-022-01840-0
Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ (2023) The immunology of long COVID. Nat Rev Immunol 23:10 [Internet] [cited 2024 May 13]. https://www.nature.com/articles/s41577-023-00904-7
Arabacı G, Cakir BS, Parris BA (2024) The effect of high-frequency rTMS over left DLPFC and fluid abilities on goal neglect. Brain Struct Funct [Internet]. [cited 2025 Jun 2];229:1073–86. Available from: https://link.springer.com/article/https://doi.org/10.1007/s00429-024-02770-y
Benedetti F, Palladini M, Paolini M, Melloni E, Vai B, De Lorenzo R et al (2021) Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study. Brain Behav Immun Health 18:100387
CAS PubMed PubMed Central Google Scholar
Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L et al (2021) Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 62:910–915
CAS PubMed PubMed Central Google Scholar
Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W et al (2022) Changes in cognitive functioning after COVID-19: A systematic review and meta‐analysis. Alzheimer’s Dement 18:1047–1066
Crook H, Raza S, Nowell J, Young M, Edison P (2021) Long covid—mechanisms, risk factors, and management. BMJ [Internet] [cited 2025 Jun 2];374. https://www.bmj.com/content/374/bmj.n1648
Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133–146
CAS PubMed PubMed Central Google Scholar
Debs P, Khalili N, Solnes L, Al-Zaghal A, Sair HI, Yedavalli V et al (2023) Post-COVID-19 brain [18F] FDG-PET findings: A retrospective Single-Center study in the united States. Am J Neuroradiol 44:517–522
CAS PubMed PubMed Central Google Scholar
Díez-Cirarda M, Yus M, Gómez-Ruiz N, Polidura C, Gil-Martínez L, Delgado-Alonso C et al (2023) Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain 146:2142–2152
Donegani MI, Miceli A, Pardini M, Bauckneht M, Chiola S, Pennone M et al (2021) Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection. Biomedicines 9:287
Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature 604:697–707
CAS PubMed PubMed Central Google Scholar
Dressing A, Bormann T, Blazhenets G, Schroeter N, Walter LI, Thurow J et al (2022) Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome. J Nucl Med 63:1058–1063
CAS PubMed PubMed Central Google Scholar
Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J [Internet]. [cited 2025 Jun 2];315:629–34. https://pubmed.ncbi.nlm.nih.gov/9310563/
Ely EW, Brown LM, Fineberg HV (2024) Long covid defined. N Engl J Med 391:1746–1753
PubMed PubMed Central Google Scholar
Frodl T, Bokde ALW, Scheuerecker J, Lisiecka D, Schoepf V, Hampel H et al (2010) Functional connectivity bias of the orbitofrontal cortex in Drug-Free patients with major depression. Biol Psychiatry 67:161–167
Fu C, Shi D, Gao Y, Xu J (2017) Functional assessment of prefrontal lobes in patients with major depression disorder using a dual-mode technique of 3D-arterial spin labeling and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Exp Ther Med 14:1058–1064
CAS PubMed PubMed Central Google Scholar
Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S et al (2023) Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging 50:1084–1089
Greene C, Connolly R, Brennan D, Laffan A, O’Keeffe E, Zaporojan L et al (2024) Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 27:421–432
CAS PubMed PubMed Central Google Scholar
Griffin MT, Werner TJ, Alavi A, Revheim ME (2023) The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19. Eur Phys J Plus 138:1–9. https://doi.org/10.1140/epjp/s13360-023-03797-6
Guedj E, Campion JY, Dudouet, Kaphan P, Bregeon E, Tissot-Dupont F et al (2021) 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging [Internet].;48:2823–33. https://doi.org/10.1007/s00259-021-05215-4
Hedges LV (1981) Distribution theory for glass’s estimator of effect size and related estimators [Internet]. [cited 2024 Jun 3];6:107–28. doi.org.ez27.periodicos.capes.gov.br/103102/10769986006002107
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382:2268–2270
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (eds) (2019) Cochrane handbook for systematic reviews of interventions. Wiley
Horowitz T, Dudouet P, Campion JY, Kaphan E, Radulesco T, Gonzalez S et al (2024) Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [18F]FDG-PET study. Eur J Nucl Med Mol Imaging 51:3215–3222
Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M et al (2021) Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144:1263–1276
Kas A, Soret M, Pyatigoskaya N, Habert MO, Hesters A, Le Guennec L et al (2021) The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging 48:2543–2557
CAS PubMed PubMed Central Google Scholar
Lakens D (2017) Equivalence tests. Soc Psychol Personal Sci 8:355–362
PubMed PubMed Central Google Scholar
Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D et al (2022) Neurovascular injury with complement activation and inflammation in COVID-19. Brain 145:2555–2568. https://doi.org/10.1093/brain/awac151
Lee M-H, Perl DP, Nair G, Li W, Maric D, Murray H et al (2021) Microvascular injury in the brains of patients with Covid-19. N Engl J Med 384:481–483
Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D et al (2022) Neurovascular injury with complement activation and inflammation in COVID-19. Brain 145:2555–2568
Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V et al (2020) Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clinical Neurophysiology [Internet] [cited 2025 Jun 2] 131:474–528. https://www.sciencedirect.com/science/article/pii/S1388245719312799?via%3Dihub#b1235
Liu EN, Yang JH, Patel L, Arora J, Gooding A, Ellis R et al (2023) Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19. J Neurol [Internet] [cited 2025 Jun 2] 270:4661–72. https://link.springer.com/article/https://doi.org/10.1007/s00415-023-11885-x
Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med [Internet] [cited 2025 Jun 27] 20:641–54. https://doi.org/10.1002/sim.698
Martini AL, Carli G, Kiferle L, Piersanti P, Palumbo P, Morbelli S et al (2022) Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. Eur J Nucl Med Mol Imaging 50:90–102
CAS PubMed PubMed Central Google Scholar
Martini AL, Carli G, Caminiti SP, Kiferle L, Leo A, Perani D et al (2024) Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms. Eur J Nucl Med Mol Imaging 52(3):810-822
Matschke J, Lütgehetmann M, Hagel C, Sperhake JP, Schröder AS, Edler C et al (2020) Neuropathology of patients with COVID-19 in germany: a post-mortem case series. Lancet Neurol 19:919–929
CAS PubMed PubMed Central Google Scholar
Meinhardt J, Streit S, Dittmayer C, Manitius Rv, Radbruch H, Heppner FL (2024) The neurobiology of SARS-CoV-2 infection. Nat Rev Neurosci 25:30–42
Nielsen NM, Spiliopoulos L, Hansen JV, Videbech P, Hviid A (2024) SARS-CoV-2 infection and risk of postacute psychiatric and neurologic diagnoses: a nationwide Danish cohort study. Neurology 102:e208113
Niesen M, Trotta N, Noel A, Coolen T, Fayad G, Leurkin-Sterk G et al (2021) Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell. Eur J Nucl Med Mol Imaging [Internet].;48:1890–901. https://pubmed.ncbi.nlm.nih.gov/33398411/
O’Mahoney LL, Routen A, Gillies C, Khunti K (2023) Response to was the rate of long Covid as high as 45%–a scary report with flaw. EClinicalMedicine. 59:101950
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a web and mobile app for systematic reviews. Syst Rev 5:1–10
Pacheco A, Figueiredo TR, Artifon JPM, Ribeiro JL da, Santos C, Magno LC (2025) LAV. Effects of an online meditation program on sleep quality, depression, anxiety, and perceived stress in liver transplant recipients: a randomized controlled trial. Mindfulness (2025). https://doi.org/10.1007/s12671-025-02639-z
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet] 372:n71. http://www.bmj.com/content/372/bmj.n71.abstract
Perego E, Callard F, Stras L, Melville-Jóhannesson B, Pope R, Alwan NA (2024) Why the patient-made term long Covid is needed. Wellcome Open Res 5:224. https://doi.org/10.12688/WELLCOMEOPENRES.16307.1
Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR et al (2022) Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol 21:148
CAS PubMed PubMed Central Google Scholar
Rau A, Schroeter N, Blazhenets G, Dressing A, Walter LI, Kellner E et al (2022) Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain 145:3203–3213
Comments (0)